Use of rapamycin and structural analogues thereof

Details Use of rapamycin and structural analogues thereof Use of rapamycin and structural analogues thereof

2003-07-03

2009-06-02

Kosar, Andrew D (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C424S078140

Reexamination Certificate

active

07541380

ABSTRACT:
The use of rapamycin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described.

REFERENCES:
patent: WO 0168147 (2001-09-01), None
Dickman, et al., Bioorganic and Medicinal Chemistry Letters, 2000, 10, 1405-1408.
Johnston,et al., Blood, 2001, 98, 410, 1 page (Abstract).
Rachmilewitz, British Journal of Haematology, 1995, 91, 263-268.
[Retrieved from] http://cancerweb.ncl.ac.uk/cgi-bin/omd?query=analog, 5 pages, 2005 [retrieved on Jul. 7, 2005].
Dickman, 2000, Bioorganic and Medicinal Chemistry Letters, 10, 1405-1408.
G. Rodgers et al., “Novel Treatment Options in the Severe β-Globin Disorders”, British Journal of Haematology, 91:263-268, 1995.
J. Rochette et al. “Fetal Hemoglobin Levels in Adults”, Blood Reviews, 8:213-224, 1994.
N. Bianchi et al., “Accumulation of γ-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine”, British Journal of Haematology, 113(4): 951-961; 2001.
Dover et al, “Increased Fetal Hemoglobin in Patients Receiving Sodium 4-Phenylbutyrate”, New England Journal of Medicine, 327:569-570, 1992.
Ikuta et al. “Cellular and Molecular Effects of a Pulse Butyrate Regimen and New Inducers of Globin Expression and Hematopoiesis” Annals of New York Academy of Sciences, 850: 87-99, 1998.
Kahan, “Sirolimus: a comprehensive review” Expert Opinion. Nov. 2001; 2(11): 1903-1917.
Dickman et al. “Antifungal Rapamycin Analogues with Reduced Immunosuppressive Activity”, Biiorganic & Medicinal Chemistry Letters 10(2000) 1405-1408.
Dell, “Antiproliferative Naphthopyrans: Biological Activity, Mechanistic Studies and Therapeutic Potential”, Current Medicinal Chemistry, 1998, 5: 179-194.
Trautmann, et al. “Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis”. Journal of Allergy Clinical Immunology, Nov. 2001 839-846.
Reitamo et al. “Efficacy of Sirolimus (rapamycin) administered concomitantly with a sub therapeutic dose of cyclosporine in the treatment of severe psoriasis: a randomized controlled trial” British Journal of Dermatology, 2001: 145: 438-445.
Guba et al. “Rapamycin inhibits primary and metastasis tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor” National Medical Feb. 2002, vol. 8, No. 2, 128-135.
Garber “Rapamycin's Resurrection: A new way to target the cancer cell cycle” National Cancer Institute, 2001, vol. 93, No. 20, 1517-1519.
Benito et al. “Sirolimus (Rapamycin) for the treatment of refractory acute graft-versus-host disease”, Transplantation, vol. 72, No. 12, Dec. 27, 2001, 1924-1929.
Radovancevic et al. “Rapamycin reduces rejection in heart transplant recipients” Transplantation Proceedings, vol. 33, 3321-3222, 2001.
Nishida et al. “Sirolimus (Rapamycin)-Based Rescue Treatment following chronic rejection after liver transplantation” Transplantation Proceedings, 33: 1495 (2001).
Bianchi et al. “Induction of Erythroid Differentiation of Human K562 Cells by Cisplatin Analogs” Biochemical Pharmacology vol. 60, 31-40, 2000.
Bianchi et al. “The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells”. British Journal of Haematology, 1999 104:258-265.
Fibach, “Techniques for Studying Stimulation of Fetal Hemoglobin Production in Human Erythroid Cultures”, Hemoglobin, 22(5&Λ), 445-458, 1998.
Fibach et al. “Hydroxyurea Increases Fetal Hemoglobin in Cultured Erythroid Cells Derived From Normal Individuals and Patients with Sickle Cell Anemia or β-Thalassemia” Blood, vol. 81, No. 6 (Mar. 15), 1993:1630-1963.
Heid et al. “Real Time Quantitative PCR”, Genome Research, 6:986-994, 1996.
Gibson et al. “A Novel Method for Real Time Quantitative RT-PCR”, Genome Research, 6:995-1001, 1996.
Johnson Julie et al.: “Treatment of beth-thalassemia in the mouse by regulated expression of AAV—encoded erythropoietin” Blood, vol. 98. No. 11 part 2, Nov. 16, 2001, pp. 410b XP009023880.
43rdAnnual Meeting of the American Society of Hematology. Part 2: Orlando, Florida< USA; Dec. 7-11, 2001 ISSN: 0006-4971.
WO 0168147 A Bianchi Nicoletta; Feriotto Giordana(IT); Gambari Roberto (IT): m) Sep. 20, 2001 p. 1, Paragraph 1-3, p. 5, Paragraph 1.

Affiliated with

Also associated with

Rating

Use of rapamycin and structural analogues thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of rapamycin and structural analogues thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of rapamycin and structural analogues thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4103605